Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.

BJU international - 5 Aug 2008

Ma Xin, Xu Hua, Zheng Tao, Li Hong-Zhao, Shi Tao-Ping, Wang Bao-Jun, Ju Zheng-Hua, Wang Chao, Zhang Guo-Xi, Zhang Xu

Abstract excerpt

OBJECTIVE: To investigate the association between DNA polymorphisms, including single-nucleotide polymorphisms (SNPs) and insertion/deletion polymorphisms, in exon 1 and promoter of the CDH1 gene, and the risk of transitional cell carcinoma (TCC) of the urinary bladder (TCCB). PATIENTS, SUBJECTS AND METHODS: This was a hospital-based case-control study of 180 patients with TCCB and 110 normal controls. Genomic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Antigens, CD

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cadherins

Share to Carcinoma, Transitional Cell

Share to Haplotypes

Share to Promoter Regions, Genetic

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 18384629
DOI: 10.1111/j.1464-410X.2008.07634.x

Genes

CDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA polymorphisms in exon 1 and promoter of the CDH1 gene and relevant risk of transitional cell carcinoma of the urinary bladder.PMID 18384629Read ↗

Role of CDH1 promoter polymorphism and DNA methylation in bladder carcinogenesis: a meta-analysis.Semantic proximity Read ↗

Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer.Semantic proximity Read ↗

Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder.Semantic proximity Read ↗

E-cadherin (CDH1) gene promoter polymorphism and the risk of colorectal cancer : a meta-analysis.Semantic proximity Read ↗

The CDH1 -160C/A polymorphism is associated with breast cancer: evidence from a meta-analysis.Semantic proximity Read ↗

Association between CYP1A2 gene variants -163 C/A (rs762551) and -3860 G/A (rs2069514) and bladder cancer susceptibility.Semantic proximity Read ↗

Roles of E-cadherin (CDH1) genetic variations in cancer risk: a meta-analysis.Semantic proximity Read ↗

Linking CDH1 SNPs to Gastric Cancer Risk: A Comprehensive Analysis of rs16260, rs13689, and rs9929218Semantic proximity Read ↗

E-cadherin gene polymorphisms and susceptibility to urolithiasis in Iraqi children.Semantic proximity Read ↗

The E-cadherin (CDH1)--160 C/A polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

A novel functional polymorphism C1797G in the MDM2 promoter is associated with risk of bladder cancer in a Chinese population.Semantic proximity Read ↗

Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.